Cover
Cover | Sep. 15, 2022 |
Entity Addresses [Line Items] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Sep. 15, 2022 |
Current Fiscal Year End Date | --12-31 |
Entity File Number | 001-37558 |
Entity Registrant Name | NABRIVA THERAPEUTICS PLC |
Entity Central Index Key | 0001641640 |
Entity Tax Identification Number | 00-0000000 |
Entity Incorporation, State or Country Code | L2 |
Entity Address, Address Line One | Alexandra House Office 225/227 |
Entity Address, Address Line Two | The Sweepstakes |
Entity Address, Address Line Three | Ballsbridge |
Entity Address, City or Town | Dublin 4 |
Entity Address, Country | IE |
Entity Address, Postal Zip Code | 00000 |
City Area Code | 610 |
Local Phone Number | 816-6640 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Ordinary Shares, nominal value $0.01 per share |
Trading Symbol | NBRV |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Former Address [Member] | |
Entity Addresses [Line Items] | |
Entity Address, Address Line One | 25-28 North Wall Quay |
Entity Address, Address Line Two | IFSC |
Entity Address, City or Town | Dublin 1 |
Entity Address, Country | IE |